Dolphin Medical Services (BOM:526504) Altman Z-Score: 3.70 (As of Jul. 03, 2026)


BOM:526504 Dolphin Medical Services Ltd BOM:526504
36 GF Score
Price ₹9.12
GF Value ₹2.38
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Dolphin Medical Services Altman Z-Score?

Dolphin Medical Services BOM:526504 36 Altman Z-Score is 3.70 as of Jul. 03, 2026. GuruFocus rates BOM:526504 with a GF Score™ of 36/100 and a GF Value™ of ₹2.38 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, Dolphin Medical Services ranks better than 61.88% on this metric.

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 3.53 is strong.

Dolphin Medical Services has a Altman Z-Score of 3.70, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Dolphin Medical Services's Altman Z-Score or its related term are showing as below:

BOM:526504' s Altman Z-Score Range Over the Past 10 Years
Min: -0.45   Med: -0.01   Max: 3.53
Current: 3.53

During the past 13 years, Dolphin Medical Services's highest Altman Z-Score was 3.53. The lowest was -0.45. And the median was -0.01.


Dolphin Medical Services  (BOM:526504) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Dolphin Medical Services Altman Z-Score Related Terms


Dolphin Medical Services Altman Z-Score Historical Data

* Premium members only.

The historical data trend for Dolphin Medical Services's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dolphin Medical Services Altman Z-Score Chart

Dolphin Medical Services Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 -0.01 0.45 0.30 2.06

Dolphin Medical Services Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.28 1.10 1.40 2.06

BOM:526504 vs TMO, DHR, IDXX: Altman Z-Score Comparison

For the Diagnostics & Research subindustry, Dolphin Medical Services's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dolphin Medical Services Altman Z-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dolphin Medical Services's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Dolphin Medical Services's Altman Z-Score falls into.


BOM:526504
36GF Score
Dolphin Medical Services Ltd BOM:526504
Altman Z-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dolphin Medical Services Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Dolphin Medical Services's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.0874+1.4*0+3.3*0.0057+0.6*5.8529+1.0*0.0603
=3.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2026:
Total Assets was ₹124.34 Mil.
Total Current Assets was ₹19.77 Mil.
Total Current Liabilities was ₹8.90 Mil.
Retained Earnings was ₹0.00 Mil.
Pre-Tax Income was 0.071 + 0.168 + 0.06 + 0.313 = ₹0.61 Mil.
Interest Expense was -0.024 + -0.024 + -0.024 + -0.024 = ₹-0.10 Mil.
Revenue was 1.92 + 2.061 + 1.834 + 1.686 = ₹7.50 Mil.
Market Cap (Today) was ₹137.71 Mil.
Total Liabilities was ₹23.53 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(19.768 - 8.895)/124.343
=0.0874

X2=Retained Earnings/Total Assets
=0/124.343
=0

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(0.612 - -0.096)/124.343
=0.0057

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=137.712/23.529
=5.8529

X5=Revenue/Total Assets
=7.501/124.343
=0.0603

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Dolphin Medical Services has a Altman Z-Score of 3.70 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.

Frequently Asked Questions Learn more about Altman Z-Score →
What does a Altman Z-Score of 3.70 mean?
Dolphin Medical Services (BOM:526504) has a Altman Z-Score of 3.70 as of Jul. 03, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Dolphin Medical Services and its competitors. According to the industry distribution chart, Dolphin Medical Services ranks #77 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 38.1%.
Is Dolphin Medical Services' Altman Z-Score too high?
Dolphin Medical Services' current Altman Z-Score is 3.70. The Medical Diagnostics & Research industry median Altman Z-Score is 2.42. Dolphin Medical Services' value of 3.70 is 53.2% above this industry median. Based on the distribution chart, Dolphin Medical Services ranks #77 out of 202 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Dolphin Medical Services has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dolphin Medical Services' Altman Z-Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Dolphin Medical Services ranks #77 out of 202 companies for Altman Z-Score. This puts Dolphin Medical Services in the upper half of its industry. The industry median Altman Z-Score is 2.42. Dolphin Medical Services' value of 3.70 is 53.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Diagnostics & Research company?
The median Altman Z-Score among Medical Diagnostics & Research companies is 2.42, based on 202 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dolphin Medical Services's current Altman Z-Score of 3.70 is 53.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Dolphin Medical Services and its competitors. For the Medical Diagnostics & Research industry, the median Altman Z-Score is 2.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dolphin Medical Services's current Altman Z-Score is 3.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dolphin Medical Services stock overvalued right now?
Based on GuruFocus' analysis, Dolphin Medical Services (BOM:526504) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹2.38, compared to a current price of ₹9.12 — trading 283.2% above its estimated fair value. The current Altman Z-Score is 3.70 and 53.2% above the Medical Diagnostics & Research industry median of 2.42. Dolphin Medical Services' overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Dolphin Medical Services (BOM:526504), the current Altman Z-Score is 3.70 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dolphin Medical Services (BOM:526504) Overvalued in 2026?

Based on GuruFocus' analysis, Dolphin Medical Services stock appears to be overvalued. The current stock price of ₹9.12 is trading 283.2% above its estimated GF Value™ of ₹2.38. GuruFocus considers Dolphin Medical Services to be Significantly Overvalued.

Key valuation signals for BOM:526504:

  • Altman Z-Score: 3.70
  • GF Value™: ₹2.38 vs. price of ₹9.12 (283.2% above fair value)
  • GF Score™: 36/100 with 5 warning signs
  • Industry Position: 53.2% above the Medical Diagnostics & Research median (#77 of 202)

No single metric tells the full story. See the BOM:526504 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dolphin Medical Services Business Description

Address Kovelamudivari Veedhi, D.No.29-28/1-27, Suryaraopet, Vijayawada, AP, IND, 520002
Dolphin Medical Services Ltd is engaged in providing diagnostics and other allied services. It includes a range of tests covering radiology and imaging, biochemistry, pathology, and microbiology. In addition, the company is also involved in Information Technology, Biotechnology, and Herbal sectors. Services provided by the company are Diagnostic Centre provides all the services under one roof; the Ophthalmic Laser Care Centre provides total laser eye treatment as "Dolphin Nethralaya"; Teleradiology Services; Clinical Trials and Life Sciences division; Medical Equipment & Goods associated distribution; Bio-Tech Division is to provide Foods and Herbal Products and Dolphin Electronic Solution and Technologies(DEST).
36GF Score

Get the complete analysis for BOM:526504

Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹9.12
Price
₹2.38
GF Value